DfID Announce £220 Million New Fund for HIV Research
DfID have announced a new £220 million fund for HIV research which will fund projects that are developing new prevention technologies.
Deborah Jack, Chief Executive of NAT, comments:
“This long term investment promised today by the UK government is exactly what is needed if we are going to win the battle against HIV and AIDS. UK scientists are among those working to find a vaccine and develop a microbicide, both of which could save millions of lives.”
Seth Berkley, CEO and President of the International AIDS Vaccine Initiative (IAVI), comments:
“The UK government is a true leader in supporting research for new prevention technologies. Ending AIDS is a long term effort and sustaining commitment is crucial, especially now during difficult financial times.”
Dr Zeda Rosenburg, CEO of the International Parternship for Microbicides (IPM), comments:
“With this new commitment, the UK government continues its leadership in global efforts to halt the spread of HIV. The UK government’s political and financial support for new HIV prevention technologies will speed the development of crucial new tools that could help bring an end to this global pandemic.”